Proton Beam Therapy Alone for Intermediate- or High-Risk Prostate Cancer: An Institutional Prospective Cohort Study

Proton Beam Therapy Alone for Intermediate- or High-Risk Prostate Cancer: An Institutional Prospective Cohort Study

The role of proton beam therapy (PBT) as monotherapy for localized prostate cancer (PCa) remains unclear. The purpose of this study was to evaluate the efficacy and adverse events of PBT alone for these patients. Between January 2011 and July 2014, 218 patients with intermediate- and high-risk PCa w...

Full description

Bibliographic Details
Main Authors: Takeshi Arimura, Takashi Yoshiura, Kyoko Matsukawa, Naoaki Kondo, Ikumi Kitano, Takashi Ogino
Format: Article
Language:English
Published: MDPI AG 2018-04-01
Series:Cancers
Subjects:
prostate cancer
proton beam therapy
efficacy
adverse events
quality of life
sexual function
medical expenses
Online Access:http://www.mdpi.com/2072-6694/10/4/116

Internet

http://www.mdpi.com/2072-6694/10/4/116

Similar Items